GeneTex中国官方网站
  • China

肿瘤蛋白

Oncoproteins

后生动物原癌基因的产物,通常是调节细胞生长和增殖的细胞信号传导和基因表达机制的关键组成部分,当突变、扩增或是其他方式的表达失调时,这些基因可以变成细胞癌基因,其癌蛋白产物驱动致瘤细胞的生长,原癌基因的例子包括RAS基因,ERBB2MYCABL1,某些病毒或癌病毒,具有通过靶向后生动物细胞因子或途径的病毒基因组编码癌蛋白的作用,而导致癌症发生的能力。

热门研究产品
AKT antibody [N3C2], Internal

AKT antibody
(GTX121937)

Ras antibody

Ras antibody
(GTX132480)

Aurora B antibody

Aurora B antibody
(GTX130211)

 

VEGF antibody

VEGF antibody
(GTX102643)

EGFR antibody [N1-2], N-term

EGFR antibody
(GTX121919)

Phospho-EGF Receptor (Tyr1068) antibody

Phospho-EGF Receptor (Tyr1068) antibody
(GTX132810)

Her2 / ErbB2 antibody [C2C3], C-term

Her2 / ErbB2 antibody
(GTX100509)

Her2 / ErbB2 (phospho Tyr1221/Tyr1222) antibody

Her2 / ErbB2 (phospho Tyr1221/Tyr1222) antibody
(GTX133445)

PDGF Receptor beta (phospho Tyr751) antibody

PDGF Receptor beta (phospho Tyr751) antibody
(GTX133525)

Literature

单页 - Antibodies for Neuroscience Research

Promotion

GeneTex专业级抗体 夏日科研65折大优惠!

Literature

单页 - Cited Antibodies 2024 Q2

下载GeneTex最新版本的Cited Antibodies 2024 Q2单页
Newsletter
Article Alert: Acquired Resistance to Immunotherapy is Mediated by EMT and Irf6 Repression in Pancreatic Ductal Adenocarcinoma

Acquired Resistance to Immunotherapy is Mediated by EMT and Irf6 Repression in Pancreatic Cancer

Article Alert: Acquired Resistance to Immunotherapy is Mediated by EMT and Irf6 Repression in Pancreatic Ductal Adenocarcinoma
Newsletter
Article Alert: Stromal Monoamine Oxidase B Drives Prostate Cancer

Article Alert: Stromal Monoamine Oxidase B Drives Prostate Cancer

Literature

Poster - The Tumor Microenvironment (TME) - Part 2

Download the latest version of GeneTex's The Tumor Microenvironment (TME) - Part 2 poster.
Literature

Poster - The Tumor Microenvironment (TME) - Part 1

Download the latest version of GeneTex's The Tumor Microenvironment (TME) - Part 1 poster.
Promotion

GeneTex重组抗体试用计划

Promotion

您发文献 我送奖励 | 2024文献奖励方案

Newsletter
Article Alert: Tumor-associated neutrophils require CD300ld to promote cancer progression

Article Alert: Tumor-associated neutrophils require CD300ld to promote cancer progression

Newsletter
Article Alert: IFNγ-stimulated KAT8-IRF1 Condensates Activate PD-L1 Expression and Promote Immune Evasion

IFNγ刺激的KAT8-IRF1凝聚体可激活PD-L1表达并促进免疫逃逸

IFNγ-stimulated KAT8-IRF1 Condensates Activate PD-L1 Expression and Promote Immune Evasion
Newsletter
PARPs as Therapeutic Targets in Clinical Oncology

PARPs as Therapeutic Targets in Clinical Oncology

Newsletter
抑制HCK以增加免疫治疗的效果与用途

抑制HCK以增加免疫治疗的效果与用途

Newsletter
由肿瘤微环境寻找髓母细胞瘤潜力新疗法-C3a受体与TNF-α受体拮抗剂

由肿瘤微环境寻找髓母细胞瘤潜力新疗法-C3a受体与TNF-α受体拮抗剂

Newsletter
ADAM17:人类疾病中的主要“脱落酶(Sheddase)”

ADAM17:人类疾病中的主要“脱落酶(Sheddase)”

ADAM17:人类疾病中的主要“脱落酶(Sheddase)”
Newsletter
内质网

内质网

内质网是由扁平的、相连的囊组成的真核膜细胞器,负责膜蛋白和分泌型蛋白的合成...
Newsletter
用于Omicron研究的抗体和重组蛋白

用于Omicron研究的抗体和重组蛋白

WHO将SARS-CoV-2变体B.1.1.529指定为第五种关注变体(VOC),并将其命名为“Omicron”...
Newsletter

NEK7:NLRP3 炎性小体激活的重要调节剂

NEK7:NLRP3 炎性小体激活的重要调节剂
Newsletter
癌症研究冉冉升起的新星

癌症研究冉冉升起的新星

类固醇生成急性调节蛋白 1 (StAR/StARD1) 介导类固醇生成中胆固醇从线粒体外膜转运到线粒体内膜的限速步骤...
Newsletter
雄激素受体(AR-V7 剪接变体特异性)抗体

雄激素受体(AR-V7 剪接变体特异性)抗体

在晚期前列腺癌中,雄激素受体剪接变体 7 (AR-V7) 是最丰富的雄激素受体 mRNA 剪接变体...
Newsletter
通过敲除验证的整合素 β-1抗体

通过敲除验证的整合素 β-1抗体

整合素是由α和β亚基组成的异二聚体蛋白,已在哺乳动物中发现了至少 18 个 α 亚基和 8 个 β 亚基...
Literature
小冊 - Cited Antibodies

小冊 - Cited Antibodies

下载 GeneTex 最新版本的 Cited Antibodies 小册
Newsletter
NRF2激活的癌症治疗新范式

NRF2激活的癌症治疗新范式

NRF2激活的癌症治疗新范式
Articles
GeneTex 「5+1」 验证策略

GeneTex 「5+1」 验证策略

GeneTex employs various analytic validation strategies to ensure both consistent quality and specificity.
Newsletter
GeneTex推出SARS-CoV-2 (COVID-19) RBD ACE2结合活性/中和测定套组

GeneTex推出SARS-CoV-2 (COVID-19) RBD ACE2结合活性/中和测定套组

GeneTex推出SARS-CoV-2 (COVID-19) RBD ACE2结合活性/中和测定套组
Literature
单页-肿瘤科研抗体研究

单页-肿瘤科研抗体

下载GeneTex最新版本的肿瘤科研抗体单页
Newsletter
Nuclear PD-L1 Mediates Pyroptosis in Cancer Cells

Nuclear PD-L1 Mediates Pyroptosis in Cancer Cells

Nuclear PD-L1 Mediates Pyroptosis in Cancer Cells
Literature

单页 - Antibodies for Neuroscience Research

Literature

单页 - Cited Antibodies 2024 Q2

下载GeneTex最新版本的Cited Antibodies 2024 Q2单页
Literature

Poster - The Tumor Microenvironment (TME) - Part 2

Download the latest version of GeneTex's The Tumor Microenvironment (TME) - Part 2 poster.
Literature

Poster - The Tumor Microenvironment (TME) - Part 1

Download the latest version of GeneTex's The Tumor Microenvironment (TME) - Part 1 poster.
Literature
小冊 - Cited Antibodies

小冊 - Cited Antibodies

下载 GeneTex 最新版本的 Cited Antibodies 小册
Literature
单页-肿瘤科研抗体研究

单页-肿瘤科研抗体

下载GeneTex最新版本的肿瘤科研抗体单页
Literature
癌症免疫检查点

单页 - 癌症免疫检查点

下载 GeneTex 最新版本的癌症免疫检查点单页
Literature
单页-ZikaVirusResearch

单页-Zika Virus Research

下载GeneTex最新版本的Zika Virus Research单页
Literature
验证抗体精选

手册 - 抗体精选

下载 GeneTex 最新版本的抗体精选手册
Literature

海报 - 癌症信号

下载GeneTex最新版本的癌症信号海报
Literature
代谢研究

单页 - 代谢研究

下载 GeneTex 最新版本的代谢研究单页
Literature
RNA 结合蛋白

单页 - RNA 结合蛋白

下载 GeneTex 最新版本的RNA结合蛋白单页
Literature

折页 - 热门产品

下载 GeneTex 最新版本的热门产品折页
Literature
文献支持抗体

折页 - 文献支持抗体

下载 GeneTex 最新版本的文献支持抗体折页
Literature

折页 - 癌症相关领域

下載GeneTex最新版本的癌症相关领域折页
Newsletter
Article Alert: Acquired Resistance to Immunotherapy is Mediated by EMT and Irf6 Repression in Pancreatic Ductal Adenocarcinoma

Acquired Resistance to Immunotherapy is Mediated by EMT and Irf6 Repression in Pancreatic Cancer

Article Alert: Acquired Resistance to Immunotherapy is Mediated by EMT and Irf6 Repression in Pancreatic Ductal Adenocarcinoma
Newsletter
Article Alert: Stromal Monoamine Oxidase B Drives Prostate Cancer

Article Alert: Stromal Monoamine Oxidase B Drives Prostate Cancer

Newsletter
Article Alert: Tumor-associated neutrophils require CD300ld to promote cancer progression

Article Alert: Tumor-associated neutrophils require CD300ld to promote cancer progression

Newsletter
Article Alert: IFNγ-stimulated KAT8-IRF1 Condensates Activate PD-L1 Expression and Promote Immune Evasion

IFNγ刺激的KAT8-IRF1凝聚体可激活PD-L1表达并促进免疫逃逸

IFNγ-stimulated KAT8-IRF1 Condensates Activate PD-L1 Expression and Promote Immune Evasion
Newsletter
PARPs as Therapeutic Targets in Clinical Oncology

PARPs as Therapeutic Targets in Clinical Oncology

Newsletter
抑制HCK以增加免疫治疗的效果与用途

抑制HCK以增加免疫治疗的效果与用途

Newsletter
由肿瘤微环境寻找髓母细胞瘤潜力新疗法-C3a受体与TNF-α受体拮抗剂

由肿瘤微环境寻找髓母细胞瘤潜力新疗法-C3a受体与TNF-α受体拮抗剂

Newsletter
ADAM17:人类疾病中的主要“脱落酶(Sheddase)”

ADAM17:人类疾病中的主要“脱落酶(Sheddase)”

ADAM17:人类疾病中的主要“脱落酶(Sheddase)”
Newsletter
内质网

内质网

内质网是由扁平的、相连的囊组成的真核膜细胞器,负责膜蛋白和分泌型蛋白的合成...
Newsletter
用于Omicron研究的抗体和重组蛋白

用于Omicron研究的抗体和重组蛋白

WHO将SARS-CoV-2变体B.1.1.529指定为第五种关注变体(VOC),并将其命名为“Omicron”...
Newsletter

NEK7:NLRP3 炎性小体激活的重要调节剂

NEK7:NLRP3 炎性小体激活的重要调节剂
Newsletter
癌症研究冉冉升起的新星

癌症研究冉冉升起的新星

类固醇生成急性调节蛋白 1 (StAR/StARD1) 介导类固醇生成中胆固醇从线粒体外膜转运到线粒体内膜的限速步骤...
Newsletter
雄激素受体(AR-V7 剪接变体特异性)抗体

雄激素受体(AR-V7 剪接变体特异性)抗体

在晚期前列腺癌中,雄激素受体剪接变体 7 (AR-V7) 是最丰富的雄激素受体 mRNA 剪接变体...
Newsletter
通过敲除验证的整合素 β-1抗体

通过敲除验证的整合素 β-1抗体

整合素是由α和β亚基组成的异二聚体蛋白,已在哺乳动物中发现了至少 18 个 α 亚基和 8 个 β 亚基...
Newsletter
NRF2激活的癌症治疗新范式

NRF2激活的癌症治疗新范式

NRF2激活的癌症治疗新范式
Newsletter
GeneTex推出SARS-CoV-2 (COVID-19) RBD ACE2结合活性/中和测定套组

GeneTex推出SARS-CoV-2 (COVID-19) RBD ACE2结合活性/中和测定套组

GeneTex推出SARS-CoV-2 (COVID-19) RBD ACE2结合活性/中和测定套组
Newsletter
Nuclear PD-L1 Mediates Pyroptosis in Cancer Cells

Nuclear PD-L1 Mediates Pyroptosis in Cancer Cells

Nuclear PD-L1 Mediates Pyroptosis in Cancer Cells
Newsletter

GeneTex推出RAS (G12D突变体) 重组抗体 [HL10]

GeneTex的RAS(G12D突变体)重组抗体适用于IHC染色和WB。
Newsletter

Clinical trials targeting alpha-synuclein protein in Parkinson’s disease

Clinical trials targeting alpha-synuclein protein in Parkinson’s disease
Newsletter
exosome PD-L1

Improving cancer immunotherapy efficacy may depend on targeting exosomes

Improving cancer immunotherapy efficacy may depend on targeting exosomes bearing the immune checkpoint protein PD-L1
Newsletter

「胶」你怎么做!Western blot省时小密技